Individuals taking opioids were found to be more likely to report physical and mental health issues and to have more frequent dealings with the criminal justice system compared with individuals not taking opioids.
Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic PainJuly 18, 2018
The Prescribed Opioids Difficulties Scale may be effective for identifying patients using opioids for chronic noncancer pain who are worried about their usage.
Misuse of opioid drugs may affect the outcomes of treatment for alcohol use disorder, and cannabis use may predict the odds of heavy drinking at the end of treatment.
A novel, innovative initiative is being developed to help end addiction over the long term, according to a viewpoint article published online June 12 in the Journal of the American Medical Association.
In patients prescribed opioids for chronic pain, those who misuse opioids alone or in combination with alcohol may experience reduced functioning compared with those who do not misuse these substances.
Dispositional mindfulness may help reduce the risk for opioid misuse in patients with chronic pain by attenuating opioid craving and directing attention to naturally rewarding stimuli.
Researchers estimated how a range of patterns of potential opioid misuse relate to adverse outcomes during the next year.
Recent physician-prescribed opioids represent the main source of provenance of the drug in individuals age ≥65 years who misuse them.
April 28, 2018 is National Prescription Drug Take Back Day.
Package inserts of opioid analgesics may not consistently provide information regarding safe drug storage and/or disposal.
In adults age 50 or older, higher education, illicit drug use, depression, and pain interference with normal work are significantly associated with opioid misuse.
A web-based cognitive behavior therapy program may be associated with greater reductions in aberrant drug-related behavior, pain interference, and pain catastrophizing in patients with chronic pain treated with opioids who undergo treatment as usual compared with patients who undergo treatment as usual only.
Prescription opioid duration — not dosage — following surgery may be associated with a greater risk for opioid misuse in patients with no prior history of opioid use.
Patients with chronic pain and ≥1 posttraumatic stress disorder symptom, particularly numbness or detachment, have poor pain-related outcomes.
The tamper-resistant formulation of controlled-release oxycodone in Australia reduced tampering among high-risk populations.
Rates of opioid misuse and related overdoses have soared in recent years in the United States, highlighting the importance of screening tools to identify patients at high risk for adverse events from opioid use.
Patients with low back pain who are depressed are more likely to be prescribed opioids, and to be prescribed higher doses.
Women are routinely prescribed more opioid medications than they need after cesarean sections, creating a high risk for misuse.
The FDA has requested the removal of reformulated Opana ER (oxymorphone HCl; Endo) from the market.
Dr Fudin discusses concerns he has regarding the CDC guideline for prescribing opioids for chronic pain.
Most patients (85%) who discontinued long-term opioid use did so because of a clinician's, rather than a patient decision.
Six building blocks for improving the delivery of chronic opioid therapy were proposed.
Based on available evidence and guidelines, Dr Gudin recommends HCPs use a "stepwise approach" when first designing a treatment plan for patients with chronic pain.
"Ultimately, the goal is to turn our clinics into research laboratories where every single patient is characterized," noted Dr Mackey.
A high level of comorbidity exists between substance use disorders and chronic pain.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Examining the Efficacy of Different Oxygen Flow Rates for Cluster Headache Attacks
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- Daily Alcohol Use May Drive Chronic Pain in Adults With HIV
- Tools to Address the Opioid Crisis
- AHA/ACC Release Updated Guidelines for Cholesterol Management
- Women Fed Soy Formula as Infants More Likely to Experience Menstrual Pain